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Abstract: Brown adipose tissue (BAT) function may depend on its anatomical location and
developmental origin. Interscapular BAT (iBAT) regulates acute macronutrient metabolism, whilst
perivascular BAT (PVAT) regulates vascular function. Although phenotypically similar, whether these
depots respond differently to acute nutrient excess is unclear. Given their distinct anatomical locations
and developmental origins and we hypothesised that iBAT and PVAT would respond differently to
brief period of nutrient excess. Sprague-Dawley rats aged 12 weeks (n=12) were fed either a standard
(10% fat, n=6) or high fat diet (HFD: 45% fat, n=6) for 72h and housed at thermoneutrality. Following
an assessment of whole body physiology, fat was collected from both depots for analysis of gene
expression and the proteome. HFD consumption for 72h induced rapid weight gain (c. 2.6%) and
reduced serum non-esterified fatty acids (NEFA) with no change in either total adipose or depot
mass. In iBAT, an upregulation of genes involved in insulin signalling and lipid metabolism was
accompanied by enrichment of lipid-related processes and functions, plus glucagon and peroxisome
proliferator-activated receptor (PPAR) signalling pathways. In PVAT, HFD induced a pronounced
down-regulation of multiple metabolic pathways which was accompanied with increased abundance
of proteins involved in apoptosis (e.g., Hdgf and Ywaq) and toll-like receptor signalling (Ube2n).
There was also an enrichment of DNA-related processes and functions (e.g., nucleosome assembly and
histone exchange) and RNA degradation and cell adhesion pathways. In conclusion, we show that
iBAT and PVAT elicit divergent responses to short-term nutrient excess highlighting early adaptations
in these depots before changes in fat mass.
Keywords: brown fat; white fat; proteome; nutrient excess
1. Introduction
Adipose tissue function differs with its anatomical location and developmental origin [1].
For instance, whilst interscapular brown adipose tissue (iBAT) shares its lineage with skeletal muscle
(e.g., Myf5+), perivascular brown adipose tissue (PVAT) is thought to derive from vascular smooth
muscle cells (e.g., SM22α+) [1,2]. iBAT can play a role in whole body glucose, and lipid homeostasis
as well as thermoregulation through the activation of uncoupling protein 1 (UCP1) which dissipates
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chemical energy as heat bypassing the conversion of ADP to ATP [3–5]. Despite PVAT being
phenotypically similar to iBAT, i.e., abundant in UCP1 and other thermogenic genes, its primary
physiological role is the regulation of vascular function rather than systemic metabolism per se [2].
Dysfunctional BAT may contribute to obesity and associated metabolic disease, whereas compromised
PVAT may enhance the atherogenic processes due to its close proximity to and crosstalk with the
endothelium [6,7].
The effect of diet-induced obesity on BAT is well established [8], but less is known on its response
to brief periods of high-fat feeding. Central inflammation occurs after only 3-4 days of commencing a
high-fat diet (HFD) that is accompanied with central and peripheral insulin resistance, adipose tissue
inflammation and hepatic steatosis [9–16]. In humans, insulin resistance can be induced after 24h
of a saturated-fatty acid (SFA) rich diet, with longer periods of overfeeding causing similar results
to those seen in animal models [17]. Although both iBAT and PVAT contain abundant UCP1 and
express glycolytic/lipolytic genes [18], their response to brief nutrient excess is unclear. Therefore, we
determined whether iBAT and PVAT differ in their response to a short-term (i.e., 72h) caloric surplus.
Given the evidence that ambient housing temperature is a critical factor in determining adipose tissue
function [19,20], we determined the response to a HFD at thermoneutrality (Tn, 28-30◦C) so as to
mimic human physiology by studying BAT under basal conditions (i.e., when UCP1 is not active).
2. Materials and Methods
All studies were approved by the University of Nottingham Animal Welfare and Ethical Review
Board, and were carried out in accordance with the UK Animals (Scientific Procedures) Act of
1986. Twelve male Sprague-Dawley rats aged 8 weeks were purchased from Charles River (Kent,
UK). Animals were randomised (http://www.graphpad.com/quickcalcs/randomize1.cfm) to either the
control or intervention group. The study was carried out at thermoneutrality (c. 280C) to negate any
confounding effects of active BAT on the response to nutrient excess, and animals were acclimated
to this environment for 4 weeks. Following the 4 week acclimation, all animals were weighed and
received either the control diet (824050 SDS, Kent, UK) or a 45% high-fat (HFD, n=6) diet (824018
SDS, Kent, UK) for 72h. During this time, animals had ad libitum access to food and water and all
procedures were carried out under a 12:12-hour reverse light-dark cycle (i.e., the during the active
phase) so as to minimise animal stress and maximise data quality and translatability [21].
2.1. Metabolic Cages
All animals were placed in an open-circuit calorimeter known as the ‘comprehensive laboratory
animal monitoring system’ (CLAMS: Columbus Instruments, Linton Instrumentation, Diss, UK) for
the last 48h of the study. Oxygen consumption (VO2) and carbon dioxide production (VCO2) were
measured [22] and were then used to calculate energy expenditure (EE) and respiratory exchange ratio
(RER) [23,24], as previously described. Measurements were taken at 9 minute intervals for the last
24h. At the end of the 24h period, all animals were weighed and fasted overnight prior to euthanasia
by rising CO2 gradient. Relevant tissues were then rapidly dissected, weighed, snap-frozen in liquid
nitrogen and stored at -80◦C for subsequent analysis. PVAT was dissected from the aortic arch down
the thoracic aorta [25].
2.2. Gene Expression Analysis
Total RNA was extracted from iBAT and PVAT with the RNeasy Plus Micro extraction kit (Qiagen,
West Sussex, UK) using an adapted version of the single step acidified phenol-chloroform method. RNA
purity was subsequently quantified with the Nanodrop ND-100 (Nanodrop Technologies, Wilmington,
USA) and all samples were normalised to 1 ng µL−1. Reverse transcription was carried out using the
High Capacity RNA-to-cDNA kit (Life Technologies, Paisley, UK) and cDNA was then amplified on
a Touchgene Gradient thermocycler (Techne Inc, Bibby Scientific Limited, Staffordshire, UK). Genes
regulating thermogenesis, insulin signalling and energy metabolism were analysed by quantitative
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PCR on the Step One Plus q-PCR system and v.2.2 software (Applied Biosciences) using either iTaq
Universal SybrGreen mastermix (BioRad, Watford, UK) or Taqman universal mastermix (ThermoFisher,
Loughborough, UK) with rat-specific oligonucleotide primers (Sigma, Gillingham, UK) or FAM-MGB
Taqman probes (see Tables S1 and S2 for primer list). Gene expression was determined using the
GeNorm algorithm against two selected reference genes: YWHAZ and TBP (stability value M = 0.18 in
BAT and 0.25 in PVAT).
2.3. Targeted Insulin Resistance PCR Arrays
We utilised the Insulin Resistance (SAB target list) PCR Array (BioRad) to screen for 86 genes
involved in the onset of adipose tissue insulin resistance (n=3 per group). All procedures were
carried out according to manufacturers’ instructions. Validation of representative data is shown in
Supplementary data (Figure S2).
2.4. Serum Analysis
Serum was thawed gently on ice with concentrations of glucose (GAGO-20, Sigma Aldrich,
Gillingham, UK), triglycerides (LabAssay ™ Trigylceride, Wako, Neuss, Germany), non-esterified fatty
acids (NEFA)-HR(2), (Wako) and insulin (80-INSRT-E01, Alpco, Salem, NH, USA) measured following
manufacturer’s instructions.
2.5. Protein Extraction, Clean-Up and Trypsinization
Proteins were extracted by homogenisation of c. 50-100 mg of frozen tissue in 500 µL CellLytic
MT cell lysis buffer (Sigma, C3228) and 5 µL of Halt Protease Inhibitor Cocktail (Thermo, 78430)
with subsequent centrifugation at 20,000× g for 10 min. The concentration of each supernatant was
determined using the Pierce BCA Protein Assay Kit (Thermo, 23225) prior to storage at -80◦C. Lipid
and other contaminants were removed from 100 µL of each protein lysate using the ReadyPrep 2D
cleanup Kit (Biorad, 1632130) with the final protein pellet reconstituted in 100 µL of 50 mM TEAB
buffer (6 M Urea, pH 8.0). Following quantification of the post-clean up concentration each sample was
normalised (50 ug) and 5 µL of 200 mM DTT/50 mM TEAB (pH 8.0) was added to each for the reduction
of proteins over a 1 h period. Following this, 20 µL of 200 mM Iodoacetamide/50 mM TEAB (pH 8.0)
was added for alkylation (1 h) and finally, 20 µL of 200 mM DTT/50 mM TEAB (pH 8.0) to consume
unreacted Iodoacetamide (1 h) with the latter two incubations carried out in the dark. 775 µL of 50 mM
TEAB was then added to reduce the urea concentration to c. 0.6 M and Sequencing Grade Modified
Trypsin (Promega, V5113) solution was added in a final concentration of 1:20 (w:w trypsin/protein).
All samples were gently vortexed and incubated overnight for 18 h at 37◦C, following which 2.5 µL of
formic acid was added to reduce the pH and halt trypsin activity. All samples were then dried down at
60◦C for 4 h and stored at 80◦C before resuspending in liquid chromatography mass spectrometry
(LCMS) grade 5% acetonitrile in 0.1% formic acid for subsequent analysis.
2.6. Mass Spectrometry
Samples (4 µL) were injected by Eksigent 425 LC system onto a trap column (Mobile Phase A;
0.1% formic acid, B; Acetonitrile with 0.1% formic acid; YMC Triart C18 guard column 0.3 × 5 mm,
300 µm ID) at 10 µL/min mobile phase A for 2 min before gradient elution onto the analytical column
(YMC Triart C18 150 × 0.3mm ID, 3 µm) in line to a Sciex TripleTOF 6600 Duospray Source using a
50 µm electrode, positive mode +5500V. Samples were analysed in both IDA (Information Dependent
Acquisition, for the generation of a spectral library) and SWATH (Data Independent Acquisition,
to generate quantitative data) modes. The following linear gradients were used: for IDA, mobile phase
B increasing from 2% to 30% over 68 min; 40% B at 72 min followed by column wash at 80% B and
re-equilibration (87 min total run time). For SWATH, 3-30% B over 38 min; 40% B at 43 min followed
by wash and re-equilibration as before (57 min total run time). IDA acquisition mode was used with a
top 30 ion fragmentation (TOFMS m/z 400-1250; product ion 100-1500) followed by 15 sec exclusion
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using rolling collision energy, 50 ms accumulation time; 1.8 s cycle. SWATH acquisition was using 100
variable windows (optimised on sample type) 25 ms accumulation time, 2.6 s cycle (m/z 400-1250). IDA
data was searched together using ProteinPilot 5.0.2, iodoacetamide alkylation, thorough search with
emphasis on biological modifications (Swissprot rat database June 2018). SWATH data was analysed
using Sciex OneOmics software [26] extracted against the locally generated library with the parameters
12 peptides per protein, 6 transitions per peptide, XIC width 30 ppm, 5 min retention time window.
2.7. Statistical Analysis
Statistical analysis was performed in GraphPad Prism version 8.0 (GraphPad Software, San
Diego, CA). Data are expressed as Mean ± SEM and details of specific statistical tests are given in
figure legends.
Functional analysis of the proteome was performed using the Advaita Bioinformatic
iPathwayGuide software (www.advaitabio.com/ipathwayguide.html) with a fold change ± 0.5 and
confidence score cut-off of 0.75. Significantly impacted biological processes, molecular interactions and
pathways were analysed in the context of pathways obtained from the Kyoto Encyclopedia of Genes
and Genomes (KEGG) database (Release 84.0+/10-26, Oct 17) [27] and the Gene Ontology Consortium
database (2017-Nov) [28]. The Elim pruning method, which removes genes mapped to a significant
gene ontology (GO) term from more general (higher level) GO terms, was used to overcome the
limitation of errors introduced by considering genes multiple times [29].
3. Results
3.1. Short-Term HFD Downregulates Genes Involved in Thermogenesis in PVAT Only
As expected, the short period of consuming a HFD did not cause any difference in final body
weight between groups (Figure 1A), or in total fat mass (Control: 22.87±3.31; HFD: 23.51±3.68 g) or the
weight of individual fat depots (Table S3). Increased 24h energy intake (Figure 1B) led to a small but
significant increase final body weight (Figure 1C) equal to c. 2.6% body weight. Whilst there was no
change in ambulatory activity or energy expenditure (Figure 1D,F, Figure S1) the reduction in RER
(Figure 1E) reflects a shift towards fat as the major fuel substrate in the HFD group. Interestingly,
despite this rapid weight gain, there were no differences in serum insulin, glucose or triglycerides,
although NEFA was reduced (Figure 1G–J). Thermogenic genes in BAT were unaffected, whereas PVAT
was more susceptible to the HFD (Figure 2A,C). Despite similar UCP1 messenger RNA (mRNA), there
was a reduction in gene expression for β3AR, DIO2 and PRDM16 in PVAT. There were no differences
with the HFD in PGC1α, CIDEA, FGF21, CITED1, SLC36a2 or P2RX5 in iBAT, whilst only SLC36a2 was
reduced in PVAT. Markers of beige adipocytes, TBX1 and TMEM26, were expressed in both iBAT and
PVAT and the HFD only reduced TMEM26 in iBAT. The white adipocyte specific cell-surface marker,
ASC1 [30], was expressed in both iBAT and PVAT and reduced with HFD in the latter.
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Figure 1. High fat diet (HFD) modified total energy balance but had no effect on insulin, glucose, triglycerides or non-esterified fatty acids. (A) Final body weight,
(B) 24h energy intake, (C) 3 day weight gain, (D) 24h energy expenditure (EE), respiratory exchange ratio (RER) and ambulatory activity and (G–J) serum metabolites.
Data expressed as mean ± SEM, n = 6 per group. For comparison, data was analysed by either Students t-test (A–C,G–J) or two-way ANOVA (D) and Sidak post-hoc
tests. Significance denoted as * < 0.05; ** < 0.01.
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perivascular BAT (PVAT) (C). Top 20 up/down-regulated genes involved in adipose tissue insulin 
resistance in iBAT (B) and PVAT (D). Data expressed as mean (A and C, n=5-6) or fold change (B and 
D, n=3). Data were analysed by Students t-test (A and C) with significance denoted as * < 0.05 or ** < 
0.01. 
3.2. Short-term HFD alters insulin signalling pathways in a depot-specific manner 
Due to the marked reduction in thermogenic genes in PVAT in response to the HFD, a number 
of genes that regulate insulin signalling and energy metabolism were measured to determine if these 
were affected by short-term nutrient excess. Targeted array profiling demonstrated that genes 
involved in insulin signalling (i.e. Igf1, Insr, and Mapk3) and lipid metabolism (i.e. Hsl, Lpl, Acsl1 
and Srebf2) were upregulated in iBAT (Figure 2B and D). iBAT also exhibited increased expression 
of genes associated with ‘whitening’ (i.e. Lep, Retn and Adipoq) and inflammation (i.e. Tlr4, Emr1 
and Tnfrsf1b). Only four genes were down-regulated in iBAT including Pdk2 and Il6. PVAT exhibited 
a marked upregulation of Ccr4 and Cxcr3 which govern T-cell differentiation and infiltration. The 
HFD increased in markers of inflammasome activation, Pycard, Il1β and Casp1 in PVAT, concomitant 
with a down-regulation of genes governing lipid (i.e. Hsl, Pde3B, Acacb and Ppara) and glucose 
metabolism (i.e. Cs, Gys1, Irs2 and mTOR). 
3.3. Short-term high fat feeding induces divergent alterations in the BAT and PVAT proteome 
Figure 2. Summary of the effect of the HFD on differences in thermogenic genes involved in brown
adipose tissue (BAT), beige and WAT adipocyte function in interscapular BAT (iBAT) (A) and perivascular
BAT (PVAT) (C). Top 20 up/down-regulated genes involved in adipose tissue insulin resistance in iBAT
(B) and PVAT (D). Data xpressed as me n (A,C, n = 5–6) or fold change (B,D, n = 3). Data were
analysed by Students t-test A,C) with significance denoted as * < 0.05 r ** < 0.01.
3.2. Short-Term HFD Alters Insulin Signalling Pathways in a Depot-Specific Manner
Due to the marked reduction in thermogenic genes in PVAT in response to the HFD, a number of
genes that regulate insulin signalling and energy metabolism were measured to determine if these were
affected by short-term nutrient excess. Targeted array profiling demonstrated that genes involved in
insulin signalling (i.e., Igf1, Insr, and Mapk3) and lipid metabolism (i.e., Hsl, Lpl, Acsl1 and Srebf2) were
upregulated in iBAT (Figure 2B,D). iBAT also exhibited increased expression of genes associated with
‘ hitening’ (i.e., Lep, Retn and Adipoq) and inflammation (i.e., Tlr4, Emr1 and T frsf1b). Only four
genes were down-regulated in iBAT including Pdk2 and Il6. PVAT exhibited a marked upregulation of
Ccr4 and Cxcr3 which govern T-cell differentiation a infiltration. The HFD increased in markers f
inflammasome ctivation, Pycard, Il1β and Casp1 in PVAT, concomitant with a down-regulation of
genes governing lipid (i.e., Hsl, Pde3B, Acacb and Ppara) and glucose metabolism (i.e., Cs, Gys1, Irs2
and mTOR).
3.3. Short-Term High Fat Feeding Induces Divergent Alterations in the BAT and PVAT Proteome
As the HFD induced clear differences in depot response, we analysed the proteome to identify
novel proteins and pathways regulated by short-term high-fat feeding. A total of 107 proteins were
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differentially regulated in iBAT with those involved in the 20S core proteasome complex (Psma3l, ↑),
endocytosis (Vps4a, ↓), calcium signalling (Camk2d, ↓) and glycolysis (Pkm, ↑) amongst the most
significant (Table 1). In PVAT, 183 proteins were differentially regulated including those involved
in glycolysis (Pfkp, ↓), apoptosis (Hdgf,↑; Ywhaq, ↑ and Ghitm, ↓), TLR signalling (Ube2n, ↑) and
peroxisomal lipid metabolism (Acox1, ↓) (Table 2).
Table 1. Top 10 differentially regulated proteins in BAT.
Symbol Gene Name Entrez Logfc Adjpv
Psma3l Proteasome subunit alpha type-3 408248 0.793509 0.000116
Tmem126a Transmembrane protein 126A 293113 −1.83882 0.000185
Ssr3 Signal Sequence Receptor Subunit 3 81784 −1.61099 0.0002
Ccdc51 Coiled-Coil Domain Containing 51 316008 −0.693 0.000763
Pkm Pyruvate Kinase M1/2 25630 0.7335 0.00279
Vps4a Vacuolar Protein Sorting 4 Homolog A 246772 −0.71726 0.003363
Apoa4 Apolipoprotein A4 25080 −1.0162 0.004051
Prss1 Serine Protease 1 24691 0.827668 0.005684
Serpina3n Serpin Family A Member 3 24795 −0.58665 0.006792
Camk2d Calcium/Calmodulin Dependent Protein Kinase II Delta 24246 −2.55115 0.007442
Entrez gene ID (Entrez), log fold change (Logfc) where minus symbol equals downregulation, adjusted P value
(adjPval).
Table 2. Top 10 differentially regulated proteins in PVAT
Symbol Gene Name Entrez Logfc Adjpv
Pfkp Phosphofructokinase, Platelet 60416 −1.38584 0.000225
Hdgf Heparin Binding Growth Factor 114499 0.69362 0.000445
Rbmxrtl RNA-binding motif protein, X chromosome retrogene-like 307779 1.91652 0.001389
Ywhaq 14-3-3 Protein Theta 25577 0.613265 0.001405
Ghitm Growth Hormone Inducible Transmembrane Protein 290596 −0.71467 0.001854
Capza1 Capping Actin Protein Of Muscle Z-Line Subunit Alpha 1 691149 1.194102 0.002081
Mtpn Myotrophin 79215 0.669685 0.002234
Ube2n Ubiquitin Conjugating Enzyme E2 N 116725 0.80585 0.002495
B2m Beta-2-Microglobulin 24223 0.809804 0.002742
Acox1 Acyl-CoA Oxidase 1 50681 −3.50641 0.004222
Entrez gene ID (Entrez), log fold change (Logfc) where minus symbol equals downregulation, adjusted P value
(adjPval).
Gene ontology (GO) analysis demonstrated the proteins in iBAT (Table 3) were significantly
enriched for lipid-related processes and functions including positive regulation of lipid catabolic process,
high-density lipoprotein particle assembly, phosphatidylcholine-sterol O-acyltransferase activator activity and
very-low-density lipoprotein particle. In PVAT (Table 4), however, proteins were significantly enriched
for nuclear and DNA-related processes and functions, including nucleosome assembly, histone exchange,
sequence-specific DNA binding and nuclear chromosomes. Impact analysis, which combines classical
overrepresentation analysis with the perturbation of a given pathway, demonstrated that fat and
digestion, glucagon signalling and peroxisome proliferator-activated receptor (PPAR) signalling pathways
were amongst those impacted in iBAT (Figure 3A–D) whilst RNA degradation, cell adhesion molecules
and ribosome pathways were among those impacted in PVAT (Figure 3E–G).
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Table 3. GO terms enriched in BAT.
GoId GoName CountDE CountAll Pv_elim
Biological Process
GO:0039536 negative regulation of RIG-I signaling pathway 3 3 0.0011
GO:0050996 positive regulation of lipid catabolic process 4 6 0.0014
GO:0046470 phosphatidylcholine metabolic process 5 7 0.0038
GO:0030300 regulation of intestinal cholesterol absorption 3 4 0.004
GO:0034380 high-density lipoprotein particle assembly 3 4 0.004
Molecular Function
GO:0031210 phosphatidylcholine binding 3 3 0.0011
GO:0060228 phosphatidylcholine-sterol O-acyltransferaseactivator activity 3 4 0.004
GO:0003713 transcription coactivator activity 4 8 0.0054
GO:0001047 core promoter binding 3 5 0.0091
GO:0017127 cholesterol transporter activity 3 5 0.0091
Cellular Component
GO:0034366 spherical high-density lipoprotein particle 3 4 0.0041
GO:0042627 chylomicron 3 4 0.0041
GO:0005667 transcription factor complex 3 6 0.0174
GO:0034361 very-low-density lipoprotein particle 3 6 0.0174
Table 4. GO terms enriched in PVAT.
GoId GoName CountDE CountAll Pv_elim
Biological Process
GO:0006334 nucleosome assembly 8 10 0.00023
GO:0017144 drug metabolic process 5 8 0.00287
GO:0043486 histone exchange 3 3 0.00343
GO:1901655 cellular response to ketone 8 21 0.00825
GO:0021766 hippocampus development 6 14 0.0116
Molecular Function
GO:0042393 histone binding 7 8 0.000011
GO:0003785 actin monomer binding 3 3 0.0033
GO:0043565 sequence-specific DNA binding 8 23 0.0143
GO:0035091 phosphatidylinositol binding 5 8 0.0219
GO:0005506 iron ion binding 6 16 0.0227
Cellular Component
GO:0000788 nuclear nucleosome 3 3 0.0035
GO:0000784 nuclear chromosome, telomeric region 3 4 0.0123
GO:0030054 cell junction 38 183 0.0174
GO:0071013 catalytic step 2 spliceosome 5 12 0.0246
GO:0001931 uropod 3 5 0.0273
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4. Discussion
Brown adipose tissue plays a major role in regulating whole body glucose and lipid homeostasis
under cold conditions (i.e., when UCP1 is active) with apparent anti-obesity potential in rodents [8].
Here, we demonstrate that when animals are housed at thermoneutrality (i.e., when UCP1 is not active)
short-term exposure to a HFD is sufficient to induce rapid whole-body weight gain which may be due
to uptake of circulating NEFA. Furthermore, iBAT and PVAT, whilst phenotypically similar, differ in
their response to this brief period of nutrient excess. This is the first study to investigate whether these
anatomically and developmentally distinct depots [1,2] respond differently to a brief caloric surplus,
and suggests that not all BAT is similar with regards to its potential to regulate nutrient metabolism.
An important aspect of our study is the finding that adaptations in iBAT and PVAT with rapid
whole-body weight gain occur prior to increased fat mass and it is likely this weight gain is a
consequence of lipid accumulation across all fat depots. The changes in iBAT and PVAT could,
therefore, be early events in the transition from BAT to a whiter phenotype, the development of
adipose tissue dysfunction and /or adaptations in response to caloric surplus. For instance, PSMA3,
a component of the core 20S proteasome complex is upregulated in visceral adipose tissue of obese
rats [31] and is seen here to be upregulated after only 72h of HFD suggesting a potential role in the
acute and chronic adaptation to HFD in these tissues.
In BAT however, activation of the proteasome is essential for cold-induced thermogenesis with
selective induction of proteostasis in BAT improving metabolic activity and body weight independent of
insulin tolerance in diet-induced obesity [32]. In this study, downregulation of Transmembrane Protein
126a (TMEM126a) in iBAT is of particular interest. It is an inner-mitochondrial, cristae associated
transmembrane protein strongly expressed in multiple tissues in adult humans and co-localises with
ATP synthase F1 subunit alpha (ATP5A) [33,34]. Intriguingly, TMEM126 also co-localises with, and
binds to, a CD137 ligand (CD137L) in macrophages to regulate reverse signaling [35,36]. CD137 is a
common marker of beige adipocytes. Whether TMEM126a regulates mitochondrial function in iBAT
or in the development of beige adipocytes is unknown. Another mitochondrial protein, Coiled-Coil
Domain Containing 51 (CCDC51), has previously been shown to be a target of the transcription factor
iroquois homeobox 3 (IRX3). In human obesity, IRX3 is a target of the FTO risk loci with allele carriers
having increased IRX3 expression in early adipogenesis where it is proposed to regulate adipocyte
function and browning through the modulation of mitochondrial genes [37].
Our finding that the response to brief nutrient excess differs in PVAT compared to iBAT may be
explained, in part, by the proximity of PVAT to, and local interaction with, the vascular system. The
downregulation of Phosphofructokinase, Platelet (PFKP), which catalyses fructose 6-phosphate to
fructose 1,6-bisphophate, is intriguing given that elevated expression is associated with raised BMI
and obesity in genome wide association studies [38,39]. In iBAT, however, PFKP expression is induced
by cold exposure and sympathetic activation with a β3-agonist and reduced at thermoneutrality [40].
This is in line with the downregulation of both thermogenic and metabolic genes and would suggest
perturbed adipocyte function in PVAT. Furthermore, Growth Hormone Inducible Transmembrane
Protein (GHITM), a mitochondrial protein involved in cristae organisation, cytochocrome C release
and apoptosis was downregulated [41]. Alongside an upregulation of Ubiquitin Conjugating Enzyme
E2 N (Ube2n) which regulates the TLR4 signalling pathway, and genes governing the inflammasome it
points towards a pro-inflammatory, apoptotic environment in PVAT following only brief exposure to a
HFD. Interestingly, Myotrophin (MTPN) and Capping Actin Protein Of Muscle Z-Line Subunit Alpha
1 (CAPZA1), both of which play a role in the growth of actin filaments, were upregulated in PVAT. Of
these, MTPN drives the growth of cardiomyocytes and promotes cardiac hypertrophy, whilst reduced
CAPZA1 improves post-ischemic cardiac function [42,43]. Whether these proteins in PVAT signal to
the endothelium to regulate vascular remodelling is currently unknown.
The enrichment of lipid and cholesterol-related GO terms in iBAT are in accordance with a major
role in lipoprotein metabolism [44,45]. Downregulation of proteins involved in reverse-transport of
cholesterol from fat to liver and the formation of high-density lipoproteins and chylomicrons (APOA1,
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2 and 4) suggests changes in the uptake and processing of triglyceride-rich lipoproteins as fuel for
iBAT [46]. Alternatively, and in the context of the rapid whole body weight gain, perturbation of PPAR
signaling including reduced UCP1 and upregulation of white adipose adipokines i.e., adiponectin
mRNA may indicate early stages of iBAT remodeling towards a white phenotype. In contrast, the
enrichment of nuclear related GO terms in PVAT are indicative of dynamic changes in DNA replication,
repair and gene transcription [47–49]. Whether the genes and proteins in these nuclear-related pathways
act on the vascular wall to regulate vascular function following brief exposure to a HFD remains to be
determined, as does the extent to which these adaptations can be reversed.
Impact analysis further highlights the divergent response in these two BAT depots with fat digestion
and absorption glucagon signaling and PPAR signalling among those impacted in iBAT. Importantly,
downregulation of UCP1 in the PPAR signalling pathway suggests impaired BAT function which
may contribute to the rapid weight gain seen within 72h. Furthermore, downregulation of the
long-chain fatty-acid CoA ligase 5 (ACSL5) in the PPAR pathway and the Mitochondrial Aspartate
Aminotransferase 2 (GOT2), which facilitates cellular long chain fatty acid uptake and metabolite
exchange between the cytosol and mitochondria, is significant as long-chain fatty acids activate UCP1
and are the preferred fuel of BAT for adaptive thermogenesis [5]. Any adaptations of this type
could modulate NEFA handling and contribute in part to the decline in plasma NEFA with the HFD,
although TG were unaffected. Conversely in PVAT, impacted pathways included retinol metabolism,
cell adhesion molecules, ribosome and fluid shear stress and atherosclerosis. Retinoic acid regulates
adipogenesis and cell migration, differentiation, apoptosis and vascular calcification in vascular smooth
muscle cells [50]. A downregulation of Retinol Saturase (RETSAT) may also be indicative of the early
stages of PVAT dysfunction. RETSAT knockout mice exhibit increased adiposity due to an upregulation
of PPARγ and FABP4 and it is downregulated in obese humans where the infiltration of macrophages
represses its function [51,52]. Altered cell adhesion and shear stress pathways in PVAT are intriguing
due to their well-known role in driving atherogenesis [53,54]. For instance, the platelet and cell
adhesion molecule PECAM1 is essential for vascular remodeling in mice with PECAM1 knockout
mice, which are partially protected from atherosclerosis, exhibiting reduced aortic arch and sinus
lesions [55,56]. How these proteins in PVAT regulate vascular function is currently unknown but we
predict these may be the initial stages of PVAT dysfunction in response to a HFD and, as such, could be
important in the initial stages of vascular dysfunction.
5. Conclusions
In conclusion, we show that two anatomically and developmentally distinct BAT depots exhibit a
divergent response to short-term nutrient excess. We propose these alterations, which occur following
rapid weight gain but prior to increased fat mass, are of importance in the development of subsequent
adipocyte dysfunction in obesity.
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